These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12918887)

  • 1. Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction.
    Sadeghi-Nejad H; Sherman N; Lue J
    Int J Clin Pract; 2003; 57(6):484-7. PubMed ID: 12918887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lower urinary tract symptoms and erectile dysfunction.
    Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
    Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
    J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbal and vitamin supplement use in a prostate cancer screening population.
    Barqawi A; Gamito E; O'Donnell C; Crawford ED
    Urology; 2004 Feb; 63(2):288-92. PubMed ID: 14972473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of international index of erectile function with nocturnal penile tumescence and rigidity testing in evaluation of erectile dysfunction.
    Tokatli Z; Akand M; Yaman O; Gulpinar O; Anafarta K
    Int J Impot Res; 2006; 18(2):186-9. PubMed ID: 16151473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
    Barqawi AB; Myers JB; O'Donnell C; Crawford ED
    BJU Int; 2007 Oct; 100(4):853-7. PubMed ID: 17662074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for erectile dysfunction in the primary care practice: results of a survey.
    Hakim J; Subit M; Maroon M; Jacques CH; Zaslau S
    W V Med J; 2005; 101(2):67-70. PubMed ID: 16042090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual activity and erectile dysfunction in elderly men with angiographically documented coronary artery disease.
    Justo D; Arbel Y; Mulat B; Mashav N; Saar N; Steinvil A; Heruti R; Banai S; Lerman Y
    Int J Impot Res; 2010; 22(1):40-4. PubMed ID: 19759541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark.
    Lyngdorf P; Hemmingsen L
    Int J Impot Res; 2004 Apr; 16(2):105-11. PubMed ID: 14973529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment.
    Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE
    Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and other lifestyle factors in relation to erectile dysfunction.
    Polsky JY; Aronson KJ; Heaton JP; Adams MA
    BJU Int; 2005 Dec; 96(9):1355-9. PubMed ID: 16287457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age.
    Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE
    J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of erectile dysfunction in men screened for prostate cancer.
    Bianco FJ; McHone BR; Wagner K; King A; Burgess J; Patierno S; Jarrett TW
    Urology; 2009 Jul; 74(1):89-93. PubMed ID: 19428072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study.
    Fung MM; Bettencourt R; Barrett-Connor E
    J Am Coll Cardiol; 2004 Apr; 43(8):1405-11. PubMed ID: 15093875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dysfunction among Jordanian men with diabetes.
    Khatib FA; Jarrah NS; Shegem NS; Bateiha AM; Abu-Ali RM; Ajlouni KM
    Saudi Med J; 2006 Mar; 27(3):351-6. PubMed ID: 16532096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.
    Ponholzer A; Temml C; Mock K; Marszalek M; Obermayr R; Madersbacher S
    Eur Urol; 2005 Jan; 47(1):80-5; discussion 85-6. PubMed ID: 15582253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.